Tissue Processor Equipment Market: Latest Report with Forecast 2018-2027

Effective Cancer Diagnosis to Pave Potential Pathways for Tissue Processor Equipment

Increasing incidences of cancer across the globe and growing fatalities associated with this chronic disease have initiated development of novel technologies such as tissue processor equipment to diagnose chronic diseases. This factor remaining instrumental in driving the need for tissue processing, geriatric population growth rate has furthered the demand for advanced tissue processor equipment. For instance, in the United States, according to the American Cancer Society and National Center for Health Statistics, in 2017, around 1,688,780 cancer cases were recorded. Likewise, according to World Health Organization (WHO), cancer mortality rate in India has crossed 79 per 100,000 deaths and in the next three years, it is expected to grow 4 times faster among women and men. Likewise, China witnessed a massive increase in cancer cases and mortalities, particularly lung and breast cancer. Also, according to World Cancer Research Fund International, cancer has not left any European country untouched, with a majority of cases prevalent in France, particularly among men, which has driven the need for efficient diagnostic equipment.

Request Brochure of this Report@ https://www.factmr.com/connectus/sample?flag=B&rep_id=433

On the other hand, geriatric population is highly susceptible to various lifestyle disorders and diseases which has become a leading cause of mortality at the global front. This factor is severely complimented by increased life expectancy leading to growth in geriatric population worldwide on the back of advanced medical facilities and enhanced longevity, reveals WHO analysis.

For instance, the older population is growing at an unprecedented rate worldwide. As per the new report, "An Aging World: 2015" published by the United States Census Bureau, almost 8.5% of the people across the globe are aged 65 years and above. This percentage is projected to reach over 17% of the global population by 2050. As advancing age is one of the leading risk factors for cancer, the people aged 65 years and above account for almost 60% of the newly cancer cases and 70% of all cancer deaths

Against this backdrop, the demand for advanced diagnostic procedures such as tissue processor equipment is likely to shoot in the coming years, in turn complementing to the growth of the tissue processor equipment market worldwide.

Demand for Tissue Processors to Accelerate on the Back of Pathologist Shortage

Scarcity of pathologists are likely to increase delays in providing enhanced diagnostic testing services and this situation is expected to go more critical if healthcare providers or governments do not train more individuals in the pathology field. This condition can worsen owing to lack of resources deployed to attract new individuals to this sector. For example, according to the White paper titled “Digital Pathology: A New Frontier in Canadian Healthcare”, more than 370 pathologists are required in Canada, however, only 240 participants enrolled in the five year training program. In addition, an excess of 820 pathologists would be needed by end of 2020. The shortfall is likely to result in increased workload on each individual pathologist.

On similar lines, hospitals, healthcare facilities and diagnostic centers in India, United States, Russia and other developed and emerging countries are expected to witness a shortage of pathologists in the following years. As a consequence, hospitals and other diagnostic facilities across the globe are more inclined towards adopting tissue processors that can support in meeting the growing demand for efficient diagnosis, which in turn is expected to drive the growth of the tissue processor equipment market.

Technological Advancements in Tissue Processor Equipment

Development of advanced tissue processor equipment facilitate enhanced tissue quality, management of reagents, streamlining workflow and increasing productivity that has resulted in substantial cost savings. For instance, in 2016, Sakura Finetek introduced “Tissue-Tek VIP 6 AI Vacuum Infiltration Processor” to prepare pathological tissue specimens. This innovative tissue processor equipment can automatically blend specified reagents onboard in order to develop novel solutions for advanced infiltration of fatty acids. Likewise, in 2017, Leica Microsystems developed “Leica PELORIS 2”, a rapid tissue processor that is essentially an intelligent processing system featuring proactive remote-care diagnostics. Such advances in medical diagnosis is expected to fuel demand for efficient tissue processor equipment, in turn pushing their market’s growth.

Request TOC of this Report@ https://www.factmr.com/connectus/sample?flag=T&rep_id=433

Albeit their usefulness and efficiency, high cost associated with automated tissue processor equipment has been a hindrance among developing nations. Histology laboratories and hospitals in emerging economies have always shown inclination toward cheap and user-friendly alternatives for tissue processing. Lack of funds, being one of the major challenges faced by most hospitals in emerging nations are likely to hinder demand for advanced tissue processor equipment on the back of limited affordability.

About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: www.factmr.com/
Follow Us on Linkedin: www.linkedin.com/company/factmr/

This release was published on openPR.